Hiroto Inaba

    Hiroto Inaba, MD, PhD

    Associate Member, St. Jude Faculty

    Departments

    Oncology

    Divisions

    Leukemia / Lymphoma

    Contact Information

    Hiroto Inaba, MD, PhD
    Leukemia / Lymphoma
    MS 260, Room C6074
    St. Jude Children's Research Hospital
    262 Danny Thomas Place
    Memphis, TN 38105-3678
    Email: hiroto.inaba@stjude.org
    Phone: (901) 595-3144
    FAX: (901) 521-9005

    Education

    MD - Mie University School of Medicine, Japan
    PhD - Mie University School of Medicine, Japan


    Research Interests


    Selected Publications

    Baker SD, Zimmerman EI, Wang YD, Orwick S, Zatechka DS, Buaboonnam J, Neale G, Olsen SR, Enemark EJ, Shurtleff S, Rubnitz J, Mullighan CG, Inaba H. Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive acute myeloid leukemia. Clin Cancer Res August 22, 2013. [Epub ahead of print]

    Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukemia. Lancet 381(9881):1943-55, 2013.

    Inaba H, Yang J, Kaste SC, Hartford CM, Motosue M, Chemaitilly W, Triplett BM, Shook DR, Pui C-H, Leung W. Longitudinal changes in body mass and composition in survivors of childhood hematological malignancies after allogeneic hematopoietic stem cell transplantation. J Clin Oncol 30(32):3991-7, 2012.

    Rubnitz JE, Inaba H. Childhood acute myeloid leukaemia. Br J Haematol 159(3):259-76, 2012.

    Inaba H, Coustan-Smith E, Cao X, Pounds SB, Shurtleff SA, Wang KY, Raimondi SC, Onciu M, Jacobsen J, Ribeiro RC, Dahl G, Bowman WP, Taub JW, Degar B, Leung W, Downing JR, Pui C-H, Rubnitz JE, Campana D. Comparative Analysis Of Different Approaches To Measure Treatment Response In Acute Myeloid Leukemia. J Clin Oncol 30(29):3625-32, 2012.

    Rubnitz JE, Pounds S, Cao X, Jenkins L, Dahl G, Bowman WP, Taub JW, Pui CH, Ribeiro RC, Campana D, Inaba H. Treatment outcome in older patients with childhood acute myeloid leukemia. Cancer June 6, 2012.

    Inaba H, Surprise HC, Pounds S, Cao X, Howard SC, Ringwald-Smith K, Buaboonnam J, Dahl G, Bowman WP, Taub JW, Campana D, Pui CH, Ribeiro RC, Rubnitz JE. Effect of body mass index on the outcome of children with acute myeloid leukemia. Cancer, May 30, 2012.

    Inaba H, Hartford CM, Pei D, Posner MJ, Yang J, Hayden RT, Srinivasan A, Triplett BM, McCullers JA, Pui CH, Leung W. Longitudinal analysis of antibody response to immunization in paediatric survivors after allogeneic haematopoietic stem cell transplantation. Br J Haematol October 24, 2011.

    Inaba H, Bhojwani D, Pauley JL, Pei D, Cheng C, Metzger ML, Howard SC, Rubnitz JE, Sandlund JT, Ribeiro RC, Leung W, Campana D, Pui CH, Jeha S. Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological malignancies. Br J Haematol August 25, 2011.

    Motosue MS, Zhu L, Srivastava K, Stokes DC, Hudson MM, McPherson V, Srinivasan S, Krasin MJ, Green DM, Spunt SL, Inaba H. Pulmonary function after whole lung irradiation in pediatric patients with solid malignancies. Cancer July 28, 2011.

    Inaba H, Rubnitz JE, Coustan-Smith E, Li L, Furmanski BD, Mascara GP, Heym KM, Christensen R, Onciu M, Shurtleff SA, Pounds SB, Pui CH, Ribeiro RC, Campana D, Baker SD. Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia. J Clin Oncol July 18, 2011.

    Hu S, Niu H, Inaba H, Orwick S, Rose C, Panetta JC, Yang S, Pounds S, Fan Y, Calabrese C, Rehg JE, Campana D, Rubnitz JE, Baker SD. Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia. J Natl Cancer Inst 2011 Epub ahead of print.

    Pui CH, Pei D, Campana D, Bowman WP, Sandlund JT, Kaste SC, Ribeiro RC, Rubnitz JE, Coustan-Smith E, Jeha S, Cheng C, Metzger ML, Bhojwani D, Inaba H, Raimondi SC, Onciu M, Howard SC, Leung W, Downing JR, Evans WE, Relling MV. Improved prognosis for older adolescents with acute lymphoblastic leukemia. J Clin Oncol 29:386-91, 2011.

    Inaba H, Londero M, Maurer SH, Onciu M, Ge Y, Taub JW, Rubnitz JE, Raimondi SC. Acute megakaryoblastic leukemia without the GATA1 mutation following transient myeloproliferative disorder in an infant without Down syndrome. J Clin Oncol 29:e230-3, 2011.

    Inaba H, Cao X, Pounds S, Pui CH, Rubnitz JE, Ribeiro RC, Razzouk BI. Randomized trial of two dosages of prophylactic granulocyte colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia. Cancer 117:1313-20, 2011.

    Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukemia: comparison of prednisone and dexamethasone. Lancet Oncol 11:1096-106, 2010.

    Rubnitz JE, Inaba H, Dahl G, Ribeiro RC, Bowman WP, Taub J, Pounds S, Razzouk BI, Lacayo NJ, Cao X, Meshinchi S, Degar B, Airewele G, Raimondi SC, Onciu M, Coustan-Smith E, Downing JR, Leung W, Pui CH, Campana D. Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. Lancet Oncol 11:543-52, 2010.

    Inaba H, Yang J, Pan J, Stokes DC, Krasin MJ, Srinivasan A, Hartford CM, Pui CH, Leung W. Pulmonary dysfunction in survivors of childhood hematologic malignancies after allogeneic hematopoietic stem cell transplantation. Cancer 116:2020-30, 2010. PMCID: PMC2919832.

    Rubnitz JE, Inaba H, Ribeiro RC, Pounds S, Rooney B, Bell T, Pui CH, Leung W. NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia. J Clin Oncol Feb 20;28(6):955-9, 2010. PMCID: PMC2834435

    Inaba H, Stewart CF, Crews KR, Yang S, Pounds S, Pui CH, Rubnitz JE, Razzouk BI, Ribeiro RC. Combination of cladribine plus topotecan for relapsed or refractory pediatric acute myeloid leukemia. Cancer 116:98-105, 2009. PMCID: PMC151111

    Brugnoletti F, Morris EB, Laningham FH, Patay Z, Pauley JL, Pui CH, Jeha S, Inaba H. Recurrent intrathecal methotrexate induced neurotoxicity in an adolescent with acute lymphoblastic leukemia: Serial clinical and radiologic findings. Pediatr Blood Cancer 52:293-5, 2009. PMCID: PMC2605174

    Inaba H, Steeves M, Nguyen P, Geiger TL. In vivo suppression of naive CD4 T cell responses by IL-2- and antigen-stimulated T lymphocytes in the absence of APC competition. J Immunol 181:3323-35, 2008. PMCID: PMC2559971

    Inaba H, Khan RB, et al. Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178-84, 2008.

    Inaba H, Jenkins JJ, et al. Pulmonary alveolar proteinosis in pediatric leukemia. Pediatr Blood Cancer 51:66-70, 2008.

    Hu S, Niu H, Minkin P, Orwick S, Shimada A, Inaba H, et al. Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia. Mol Cancer Ther 7:1110-20, 2008.

    Inaba H, Fan Y, et al. Clinical and Biological Features and Treatment Outcome of Children With Newly Diagnosed Acute Myeloid Leukemia and Hyperleukocytosis. Cancer 113:522-9, 2008.

    Inaba H, Jones DP, et al. BK virus-induced tubulointerstitial nephritis in a child with acute lymphoblastic leukemia. J Pediatr 151:215-7, 2007.

    Inaba H, Handgretinger R, et al. Allogeneic graft-versus-hepatoblastoma effect. Pediatr Blood Cancer 46:501-5, 2006.

    Inaba H, Hale G, et al. Diagnostic challenge in recurrent skin rash after autologous bone marrow transplantation. J Pediatr Hematol Oncol 28:525-8, 2006.

    Inaba H, Geiger TL. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes. Int Immunol 18:1043-54, 2006.

    Inaba H, Geiger TL, et al. A case of hemoglobin SC disease with cold agglutinin-induced hemolysis. Am J Hematol 78:37-40, 2005.

    Inaba H, Shimada K, et al. Acquisition of Fas resistance by Fas receptor mutation in a childhood B-precursor acute lymphoblastic leukemia cell line, MML-1. Int J Oncol 27:573-9, 2005.

    Inaba H, Glibetic M, et al. Interferon-gamma sensitizes osteosarcoma cells to Fas-induced apoptosis by up-regulating Fas receptors and caspase-8. Pediatr Blood Cancer 43:729-36, 2004.

    Inaba H, Rabah R, et al. Herpes simplex virus pneumonia in a patient with ependymoma. J Pediatr Hematol Oncol 26:108-11, 2004.

    Last update: September 2013